Investing.com -- Innate Pharma SA (EPA:IPH) (NASDAQ:IPHA) stock surged 23% on Monday after the company announced that the U.S. Food and Drug Administration (FDA) completed its review of the ...
Among people in prison, adding CXR or CRP to symptom screen was more effective than symptom screen alone. In addition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback